Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Shares Issued (2020 - 2025)

Roivant Sciences' Shares Issued history spans 5 years, with the latest figure at $118.8 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 18235.49% year-over-year to $118.8 million; the TTM value through Dec 2025 reached $217.8 million, up 4.04%, while the annual FY2025 figure was $1.0 million, 98.11% down from the prior year.
  • Shares Issued reached $118.8 million in Q4 2025 per ROIV's latest filing, up from $68.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $199.8 million in Q4 2023 to a low of $648000.0 in Q4 2024.
  • Average Shares Issued over 4 years is $56.3 million, with a median of $25.6 million recorded in 2023.
  • Peak YoY movement for Shares Issued: crashed 99.68% in 2024, then skyrocketed 18235.49% in 2025.
  • A 4-year view of Shares Issued shows it stood at $94.7 million in 2022, then soared by 110.93% to $199.8 million in 2023, then plummeted by 99.68% to $648000.0 in 2024, then surged by 18235.49% to $118.8 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Shares Issued are $118.8 million (Q4 2025), $68.3 million (Q3 2025), and $30.1 million (Q2 2025).